Home » News » Twentieth research institution joins DataverseNL
Twentieth research institution joins DataverseNL
16 May 2023
From 1 May, the Amsterdam University Medical Centre (Amsterdam UMC) will use DataverseNL to publish their research data. This makes it the twentieth Dutch research institution to use our data service.
DataverseNL is a repository for research data that we provide in cooperation with participating research institutes. DANS manages the technical infrastructure, such as technical installation and maintenance, and takes care of the development of new functionalities. The institutions using DataverseNL are responsible for managing and curating the deposited research data. They can also organise their part of DataverseNL according to their own needs; create folders and subfolders for specific faculties or departments and label them with (different) logos, assign different roles with corresponding rights to users and organise the workflow for publishing research data according to their own needs.
For our DataverseNL service, we use the open source Dataverse software, developed by Harvard University. There is a global community that contributes to the continuous development of this software. For more information see: https://dataverse.org/.
More information about our DataverseNL service can be found here.
Is your institution looking for a repository for publishing research data, please contact Marion Wittenberg, our service manager DataverseNL by using the form below. If you are a researcher and would like to publish data in DataverseNL, please contact your institution.
About Amsterdam UMC
Amsterdam UMC exists since June 2018 and was created from the administrative merger of the Academic Medical Centre (AMC), belonging to the University of Amsterdam, and the VU medical centre (VUmc). Over 16,000 employees spread across two locations work together to provide good and accessible care. Amsterdam UMC focuses on a future in which diseases can be prevented and patients receive the best treatments. The focus is on the complex treatment of rare diseases. DANS is pleased to contribute to this mission by sustainably publishing anonymised research data.